BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 30066238)

  • 1. Impact of body mass index on long-term outcomes in patients undergoing percutaneous coronary intervention stratified by diabetes mellitus: a retrospective cohort study.
    Rao C; Zhong Q; Wu R; Li Z; Duan Y; Zhou Y; Wang C; Chen X; Wang R; He K
    BMC Cardiovasc Disord; 2024 Feb; 24(1):113. PubMed ID: 38365597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of sex, body mass index and chronic kidney disease on outcomes following percutaneous coronary intervention.
    Bimal T; Bhuiyan MR; Fishbein J; Ukrani J; Gandotra P; Selim S; Ong L; Gruberg L
    Cardiovasc Revasc Med; 2024 Feb; 59():37-45. PubMed ID: 37604707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who underwent Percutaneous Coronary Intervention: An Australian Cohort Analysis.
    O'Brien JM; Dinh D; Roberts L; Teh A; Brennan A; Duffy SJ; Clark D; Ajani A; Oqueli E; Sebastian M; Reid C; Econ CH; Freeman M; Chandrasekhar J;
    Am J Cardiol; 2024 May; 219():25-34. PubMed ID: 38447892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Body Mass Index and Clinical Outcomes According to Diabetes in Patients Who Underwent Percutaneous Coronary Intervention.
    Kim BG; Hong SJ; Kim BK; Lee YJ; Lee SJ; Ahn CM; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Korean Circ J; 2023 Dec; 53(12):843-854. PubMed ID: 37973975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body Mass Index and All-Cause Mortality in Elderly Patients with Percutaneous Coronary Intervention: A Meta-Analysis.
    Wang Y; Li J; Zhang Y; Chen S; Zheng F; Deng W
    Obes Facts; 2024; 17(3):227-236. PubMed ID: 38354715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique referral system contributes to long-term net clinical benefits in patients undergoing secondary prevention therapy after percutaneous coronary intervention.
    Kageyama S; Murata K; Nawada R; Onodera T; Maekawa Y
    PLoS One; 2020; 15(11):e0242707. PubMed ID: 33211778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and associated factors in patients who underwent percutaneous coronary intervention: a multicenter study in Ethiopia.
    Tona WM; Tamiru MT; Beyene DA; Tegegne GT; Alemkere G; Shashu BA; Tadesse TA
    Acta Cardiol; 2024 Jun; ():1-9. PubMed ID: 38884451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact Of body Mass Index on Cardiopulmonary Outcomes of COVID-19 Hospitalizations Complicated by Severe Sepsis.
    Neppala S; Chigurupati HD; Mopuru NN; Alle NR; James A; Bhalodia A; Shaik S; Bandaru RR; Nanjundappa A; Sunkara P; Gummadi J; Desai R
    Obes Pillars; 2024 Jun; 10():100101. PubMed ID: 38435542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    Bohula EA; Wiviott SD; McGuire DK; Inzucchi SE; Kuder J; Im K; Fanola CL; Qamar A; Brown C; Budaj A; Garcia-Castillo A; Gupta M; Leiter LA; Weissman NJ; White HD; Patel T; Francis B; Miao W; Perdomo C; Dhadda S; Bonaca MP; Ruff CT; Keech AC; Smith SR; Sabatine MS; Scirica BM;
    N Engl J Med; 2018 Sep; 379(12):1107-1117. PubMed ID: 30145941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and in-hospital complications of catheter ablation for atrial fibrillation in patients with obesity and morbid obesity.
    Prasitlumkum N; Chokesuwattanaskul R; Kaewput W; Thongprayoon C; Bathini T; Boonpheng B; Vallabhajosyula S; Cheungpasitporn W; Jongnarangsin K
    Clin Cardiol; 2022 Apr; 45(4):407-416. PubMed ID: 35170775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Kinase Insert Domain (KDR) Gene Polymorphism rs2305948 on Clopidogrel Resistance in Iraqi Patients Undergoing Elective Percutaneous Coronary Intervention (PCI).
    Ahmed AA; Amber KI; Hadi NR
    Acta Inform Med; 2020 Sep; 28(3):202-208. PubMed ID: 33417661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverted U-shaped relationship between body mass index and multivessel lesions in Chinese patients with myocardial infarction: a cross-sectional study.
    Sun D; Li W; Zhang H; Li Y; Zhang Q
    J Int Med Res; 2020 Jul; 48(7):300060520932820. PubMed ID: 32692271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between body mass index and clinical outcomes after new-generation drug-eluting stent implantation: Korean multi-center registry data.
    Kim BG; Hong SJ; Kim BK; Ahn CM; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2018 Oct; 277():155-162. PubMed ID: 30216914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: The landmark analysis from Tokyo-MD PCI registry.
    Ueshima D; Ashikaga T; Yoshikawa S; Sasaoka T; Hatano Y; Kurihara K; Maejima Y; Isobe M
    J Cardiol; 2017 Jun; 69(6):815-822. PubMed ID: 27692568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hypercholesterolemia Paradox in Percutaneous Coronary Intervention: An Analysis of a Multicenter PCI Registry.
    Ueshima D; Yoshikawa S; Sasaoka T; Hatano Y; Kurihara K; Maejima Y; Isobe M; Ashikaga T
    Intern Med; 2019 Feb; 58(3):345-353. PubMed ID: 30210130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity score-matched analysis of coronary artery bypass grafting versus second-generation drug-eluting stents for triple-vessel disease.
    Nishigawa K; Fukui T; Hagiya K; Tobaru T; Uemura K; Takanashi S
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1152-1159. PubMed ID: 30561571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.
    Akin I; Tölg R; Hochadel M; Bergmann MW; Khattab AA; Schneider S; Senges J; Kuck KH; Richardt G; Nienaber CA;
    JACC Cardiovasc Interv; 2012 Feb; 5(2):162-9. PubMed ID: 22361600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity paradox in the era of percutaneous coronary intervention with 2nd-generation drug-eluting stents: an analysis of a multicenter PCI registry.
    Ueshima D; Yoshikawa S; Sasaoka T; Hatano Y; Kurihara K; Maejima Y; Isobe M; Ashikaga T
    Heart Vessels; 2019 Feb; 34(2):218-226. PubMed ID: 30066238
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.